Cargando…
P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429402/ http://dx.doi.org/10.1097/01.HS9.0000847100.49572.31 |
| _version_ | 1784779431849492480 |
|---|---|
| author | Passamonti, F. Lou, Y. Chevli, M. Abraham, P. |
| author_facet | Passamonti, F. Lou, Y. Chevli, M. Abraham, P. |
| author_sort | Passamonti, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429402 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94294022022-08-31 P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION Passamonti, F. Lou, Y. Chevli, M. Abraham, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429402/ http://dx.doi.org/10.1097/01.HS9.0000847100.49572.31 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Passamonti, F. Lou, Y. Chevli, M. Abraham, P. P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION |
| title | P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION |
| title_full | P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION |
| title_fullStr | P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION |
| title_full_unstemmed | P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION |
| title_short | P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION |
| title_sort | p1058: real-world outcomes with fedratinib therapy in patients with primary myelofibrosis post-ruxolitinib discontinuation |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429402/ http://dx.doi.org/10.1097/01.HS9.0000847100.49572.31 |
| work_keys_str_mv | AT passamontif p1058realworldoutcomeswithfedratinibtherapyinpatientswithprimarymyelofibrosispostruxolitinibdiscontinuation AT louy p1058realworldoutcomeswithfedratinibtherapyinpatientswithprimarymyelofibrosispostruxolitinibdiscontinuation AT chevlim p1058realworldoutcomeswithfedratinibtherapyinpatientswithprimarymyelofibrosispostruxolitinibdiscontinuation AT abrahamp p1058realworldoutcomeswithfedratinibtherapyinpatientswithprimarymyelofibrosispostruxolitinibdiscontinuation |